top of page
  • Writer's pictureVictoria Holl

Millennium Alliance Podcast: Advancing Healthcare through Secure Data Collaboration

June 2023



Omer Dror, CEO and co-founder of Lynx.MD was recently interviewed by Conor Tuohy for the Millennium Alliance Live podcast. The conversation explores the history of Lynx.MD, the company vision, and the importance of data collaboration in healthcare and research. In a world rich with healthcare data, the potential to transform patient care and save lives is within our reach. However, accessing and harnessing the insights buried in notes and siloed data repositories is a monumental challenge. Lynx.MD, an AI-powered medical data intelligence platform, is on a mission to unlock the untapped potential of real-world data by providing a secure and self-service analytics platform.


  1. Can you tell us about your company's mission? Lynx.MD's mission is to bridge the gap between real-world patient data and transformative research, enabling diagnostic and therapeutic solutions that improve patient outcomes. The healthcare industry has amassed an immense amount of data that, if accessible, could revolutionize care and save lives. Real-world data holds tremendous potential—from detecting diagnostic risk factors in medical images to repurposing drugs, designing clinical trials, and conducting population-level analyses. However, to fully leverage this potential, effective collaboration within the healthcare ecosystem is crucial. Lynx.MD aims to provide a secure and safe platform that facilitates the sharing of sensitive data without compromising patient confidentiality or breaching data security regulations.

  2. How does Lynx work with healthcare providers, researchers, and other stakeholders to promote data collaboration? Lynx.MD brings together healthcare providers, researchers, academics, and MedTech organizations to foster collaboration with real-world clinical data. One of the biggest barriers to collaboration is inertia—aggregating data from disparate sources and managing access requests is not a top priority for most healthcare organizations. Meanwhile, researchers and academics require real-world data to test hypotheses, understand treatment effectiveness, patient outcomes, and advance personalized medicine. To address these challenges, Lynx.MD has developed a secure data exchange platform that connects healthcare providers, industry researchers, academics, and MedTech organizations. The platform enables the safe and secure sharing of de-identified clinical data, empowering transformative analytics and accelerating research and development.

  3. Why is data sharing so important in healthcare, research, and development, and what problem are you solving? Data sharing and collaboration are crucial for improving patient care. It accelerates scientific discoveries, enhances reproducibility, promotes innovation, shortens time to market, improves patient outcomes, optimizes resource allocation, and addresses public health challenges. The rapid development of COVID-19 vaccines exemplifies the power of data sharing enabled by platforms like the UK's NHS Data sharing platform or Israel's centralized healthcare data repository. These countries contributed de-identified data from millions of individuals, enabling pharmaceutical companies to test hypotheses and track efficacy in real time. Lynx.MD aims to provide healthcare providers with a similar platform to safely and securely share data, enabling research and development that can improve care and outcomes.

  4. What sets the Lynx.MD platform apart from other solutions in the industry? The Lynx.MD platform stands out by bringing both sides of the data ecosystem together for collaboration. Healthcare organizations trust Lynx.MD to connect and collate their data from various sources into a secure Trusted Data Environment. This environment allows them to use the data for internal analysis and research or selectively share it with third parties for further advancements. Importantly, the data never leaves the provider's secure environment, ensuring control and compliance. Additionally, MedTech, biopharma, and life science companies can significantly reduce the time to access real-world clinical data by partnering with Lynx.MD, leveraging the data aggregated from healthcare partners. Previously, these organizations would have had to navigate individual contracts with each provider, a process that could.

Thank you to the Millennium Alliance for hosting Lynx.MD. We appreciate the opportunity to engage in discussions about the challenges and opportunities presented by the vast amount of healthcare data, which unfortunately remains inaccessible and confined within siloed data structures. Approximately 97% of this valuable data is currently locked away, hindering its utilization. Organizations like the Millennium Alliance play a vital role in advancing new technologies and initiatives, bringing them to the forefront of the healthcare industry.



bottom of page